Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-24), Oneview Healthcare's 1-Year Sharpe Ratio is -0.37.
Oneview Healthcare (ASX:ONE) 1-Year Sharpe Ratio Explanation
The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
Oneview Healthcare 1-Year Sharpe Ratio Related Terms
ASX:ONE vs VEEV, BTSG, TEM: 1-Year Sharpe Ratio Comparison
For the Health Information Services subindustry, Oneview Healthcare's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's 1-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's 1-Year Sharpe Ratio falls into.
Oneview Healthcare 1-Year Sharpe Ratio Calculation
The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.
Oneview Healthcare (ASX:ONE) has a 1-Year Sharpe Ratio of -0.37 as of Jul. 24, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Oneview Healthcare and its competitors.
Is Oneview Healthcare's 1-Year Sharpe Ratio too high?
Oneview Healthcare's current 1-Year Sharpe Ratio is -0.37. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's 1-Year Sharpe Ratio compare to VEEV and BTSG?
Oneview Healthcare's 1-Year Sharpe Ratio of -0.37 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Oneview Healthcare and its competitors. Oneview Healthcare's current 1-Year Sharpe Ratio is -0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.17 — trading 48.5% below its estimated fair value. The current 1-Year Sharpe Ratio is -0.37. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current 1-Year Sharpe Ratio is -0.37 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.17 is trading 48.5% below its estimated GF Value™ of A$0.33.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
1-Year Sharpe Ratio: -0.37
GF Value™: A$0.33 vs. price of A$0.17 (48.5% below fair value)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score
Get the complete analysis for ASX:ONE
1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
